Vismodegib is a prescription medicine used to treat adults with a certain type of cancer called basal cell carcinoma (BCC) that has spread to other parts of the body or cannot be treated with surgery or radiation. Vismodegib works by blocking a protein called the Hedgehog pathway. This pathway is thought to be important for the growth and spread of some types of cancer. Vismodegib is a pill that is taken once daily.
Vismodegib is a medication used to treat a specific type of skin cancer. Here's a breakdown of its key aspects:
Type of medication:
- Vismodegib is an orally available small-molecule inhibitor. This means it's a drug taken by mouth that acts by blocking a specific molecule involved in cancer cell growth.
Condition treated:
- Vismodegib is specifically approved for the treatment of basal cell carcinoma with locally advanced or metastatic hedgehog pathway mutation.
- Basal cell carcinoma is the most common type of skin cancer, but it usually grows slowly and can be effectively treated with surgery or other methods.
- Vismodegib is typically used for more advanced cases where the cancer has spread beyond the original site (metastatic) or cannot be treated with surgery or radiation.
- The hedgehog pathway mutation refers to a specific genetic abnormality in the cancer cells that drives their growth. Vismodegib targets this pathway.
How it works:
- Vismodegib works by inhibiting a protein called Smoothened (SMO) which is part of the hedgehog signaling pathway.
- This pathway plays a crucial role in the development and growth of various cells, including cancer cells.
- By blocking SMO, Vismodegib disrupts the hedgehog pathway and hinders the growth and survival of cancer cells with this specific mutation.
Dosage and administration:
- Vismodegib comes in capsule form and is taken orally, typically once a day.
- The doctor will determine the appropriate dosage and treatment duration based on individual needs and response to the medication.
Common side effects:
- Vismodegib can cause several side effects, some of the most common ones include:
- Muscle cramps or pain
- Hair loss
- Fatigue
- Nausea
- Diarrhea
- Taste changes
- Loss of appetite
- It's important to talk to your doctor about any side effects you experience.
Important considerations:
- Vismodegib is a prescription medication and should only be taken under the supervision of a qualified dermatologist or oncologist (cancer doctor) experienced in treating basal cell carcinoma with hedgehog pathway mutations.
- Vismodegib can interact with other medications, so it's crucial to tell your doctor about all medications you are taking.
- Vismodegib can cause birth defects, so pregnancy should be avoided during treatment and for a certain period after stopping the medication. Women who are breastfeeding should not take Vismodegib.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01X - Other antineoplastic agents
L01XJ Hedgehog pathway inhibitors
ATC Code
External Links
Vismodegib